GlassScriptPhysician profile
Eddie Thara
NPI 1932436821
$34,553.29
in general payments reported to CMS, 2019-2025
100 companies · $5,786 in 2025
The $5,786 reported for 2025 was more than what 83% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,708 · 2020: $3,710 · 2021: $4,058 · 2022: $4,563 · 2023: $5,598 · 2024: $7,131 · 2025: $5,786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $835 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,512.35 |
| Education | $835.29 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,432.55 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,139.86 | 2019-2025 | Calquence, Tagrisso, Lynparza |
| Pfizer INC. | $1,709.67 | 2019-2025 | |
| Incyte Corporation | $1,579.84 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Merck Sharp & Dohme LLC | $1,536.53 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $1,533.81 | 2019-2025 | Opdivo, Opdualag |
| Celgene Corporation | $1,422.48 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Janssen Biotech, INC. | $1,257.14 | 2019-2025 | Darzalex, Carvykti, Imbruvica |
| Abbvie INC. | $1,088.64 | 2019-2025 | |
| Eisai INC. | $1,045.75 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,012.17 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Regeneron Healthcare Solutions, INC. | $945.48 | 2020-2025 | Libtayo |
| Amgen INC. | $893.14 | 2019-2023 | Xgeva, Nplate, Vectibix |
| Bayer Healthcare Pharmaceuticals INC. | $888.41 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $823.06 | 2019-2023 | Imbruvica, Epkinly |
Show all 94 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $801.57 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Lilly USA, LLC | $769.39 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Gilead Sciences, INC. | $668.22 | 2021-2025 | Trodelvy |
| Daiichi Sankyo INC. | $630.29 | 2019-2025 | Enhertu, Datroway |
| Genzyme Corporation | $604.58 | 2019-2025 | |
| Genentech USA, INC. | $558.61 | 2019-2025 | Tecentriq, Alecensa |
| Glaxosmithkline, LLC. | $542.23 | 2020-2025 | Jemperli, Ojjaara, Zejula |
| Aveo Pharmaceuticals, INC. | $533.29 | 2022-2024 | Fotivda |
| Secura Bio, INC. | $487.78 | 2019-2025 | Copiktra |
| Beigene USA, INC. | $442.66 | 2021-2025 | Brukinsa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $430.25 | 2019-2025 | Gilotrif |
| Array Biopharma INC | $422.83 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Alexion Pharmaceuticals, INC. | $403.11 | 2019-2025 | Ultomiris |
| Exelixis INC. | $399.12 | 2019-2025 | Cabometyx |
| Emd Serono, INC. | $343.93 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $332.51 | 2020-2025 | Xpovio |
| Puma Biotechnology, INC. | $303.19 | 2019-2025 | |
| Seagen INC. | $293.15 | 2019-2025 | Tivdak |
| Kite Pharma, INC. | $278.00 | 2020-2022 | |
| Foundation Medicine, INC. | $271.16 | 2020-2023 | Foundationone Liquid Cdx |
| Blueprint Medicines Corporation | $226.22 | 2020-2025 | Ayvakit |
| Beone Medicines USA, INC. | $218.34 | 2025 | Brukinsa |
| Ipsen Biopharmaceuticals, INC | $207.36 | 2020-2025 | Somatuline Depot, Onivyde |
| Adaptive Biotechnologies Corporation | $203.20 | 2022-2025 | Clonoseq |
| Rigel Pharmaceuticals, INC. | $201.53 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Taiho Oncology, INC. | $176.02 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $171.02 | 2023-2025 | Zepzelca |
| Coherus Oncology, INC. | $151.33 | 2020-2024 | |
| Pharmaessentia USA Corporation | $147.89 | 2023-2025 | Besremi |
| Sobi, INC | $145.13 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $138.16 | 2022-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $136.36 | 2019-2022 | |
| Genmab U.S., INC. | $136.22 | 2023-2025 | Epkinly |
| Caris Mpi, INC. | $134.96 | 2025 | Mi Cancer Seek |
| Servier Pharmaceuticals LLC | $119.19 | 2021-2024 | |
| Cardinal Health 110 LLC | $113.00 | 2023 | |
| Dova Pharmaceuticals | $111.49 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $111.20 | 2024-2025 | |
| Kyowa Kirin, INC. | $104.62 | 2023-2025 | Poteligeo |
| Sanofi-Aventis U.S. LLC | $101.74 | 2019-2022 | |
| Myovant Sciences INC. | $100.81 | 2022 | |
| Mirati Therapeutics, INC. | $98.17 | 2023-2024 | Krazati |
| Epizyme, INC. | $97.85 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $97.54 | 2023-2025 | Orgovyx |
| Verastem, INC. | $88.11 | 2019-2020 | |
| Adc Therapeutics America, INC. | $79.96 | 2023-2025 | |
| Agios Pharmaceuticals, INC. | $79.89 | 2019-2023 | Pyrukynd |
| Recordati_rare_diseases_inc. | $72.83 | 2023-2025 | Sylvant, Enjaymo |
| Octapharma USA, INC. | $59.01 | 2019-2024 | Octagam Immune Globulin (Human) |
| Morphosys, US INC. | $58.86 | 2021-2023 | Monjuvi |
| Deciphera Pharmaceuticals INC. | $56.23 | 2021-2024 | Qinlock |
| Springworks Therapeutics, INC. | $53.91 | 2024 | Ogsiveo |
| Global Blood Therapeutics, INC. | $53.84 | 2020-2022 | |
| Eusa Pharma (US) LLC | $46.12 | 2020 | |
| Novocure INC. | $41.18 | 2020-2021 | |
| Acceleron Pharma, INC. | $40.43 | 2020-2021 | |
| Partner Therapeutics, INC. | $34.75 | 2019-2020 | |
| Csl Behring | $33.15 | 2019 | |
| Aurobindo Pharma USA, INC. | $30.11 | 2020 | |
| Organon LLC | $29.69 | 2021-2023 | |
| Janssen Scientific Affairs, LLC | $29.29 | 2019 | |
| Tempus Ai, INC | $29.28 | 2024 | |
| Immunocore Limited | $29.20 | 2024 | Kimmtrak |
| Cti Biopharma Corp. | $27.10 | 2023 | Vonjo |
| Immunogen, INC. | $26.54 | 2023 | Elahere |
| Lexicon Pharmaceuticals, INC. | $24.20 | 2020 | |
| Pharmacosmos Therapeutics INC. | $24.02 | 2023 | Monoferric |
| Myriad Genetic Laboratories, INC. | $24.00 | 2022 | |
| Mallinckrodt Hospital Products INC. | $23.89 | 2020 | |
| Stemline Therapeutics INC. | $23.46 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $22.57 | 2019 | |
| Clovis Oncology, INC. | $21.96 | 2019 | |
| Tesaro, INC. | $21.41 | 2019 | |
| Mylan Institutional INC. | $17.08 | 2019 | |
| Shorla Oncology INC. | $16.73 | 2025 | |
| Emmaus Medical, INC. | $16.45 | 2024 | Endari |
| West Therapeutics Development, LLC | $16.13 | 2019 | |
| Optos, INC. | $14.21 | 2021 | |
| Chiesi USA, INC. | $13.95 | 2024 | Ferriprox |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Imbruvica $832Calquence $770Keytruda $709Epkinly $656Libtayo $649Brukinsa $616Reblozyl $601Enhertu $579Kisqali $545Jakafi $453Elrexfio $412Lenvima $385Verzenio $379Jaypirca $373Fotivda $367Copiktra $359Xtandi $348Braftovi $345Adcetris $342Mektovi $315Bosulif $310Lynparza $300Opdivo $298Elahere $271Tagrisso $258Darzalex $255Tukysa $222Orgovyx $209Monjuvi $208Padcev $203Jemperli $200Lorbrena $200Vitrakvi $200Stivarga $200Nubeqa $197Trodelvy $195Ninlaro $194Fruzaqla $185Talzenna $185Tecentriq $184Cabometyx $182Onivyde $178Somatuline Depot $178Carvykti $174Ayvakit $172Xofigo $170Retevmo $162Ultomiris $154Welireg $153Ibrance $149Besremi $148Zepzelca $143Udenyca $135Mi Cancer Seek $135Xpovio $134Clonoseq $133Sarclisa $132Fabhalta $131Tecvayli $130Inlyta $128Pomalyst $124Opdualag $122Alunbrig $114Doptelet $113Yonsa $111Odomzo $111Gilotrif $107Poteligeo $105Lonsurf $104Inqovi $104Pemazyre $104Krazati $98.17Scemblix $97.50Pylarify $94.30Pluvicto $92.52Tavalisse $88.82Rezlidhia $88.82Rybrevant $85.61Nerlynx $75.86Talvey $71.67Erleada $65.51Balversa $65.51Iclusig $63.50Vonjo $59.33Datroway $59.05Zynyz $58.96Jevtana $57.96Ogsiveo $53.91Comirnaty $52.09Besponsa $50.51Sylvant $48.82Keytruda Qlex $47.90Foundationone Liquid Cdx $47.81Promacta $39.77Ojjaara $39.31Mekinist $38.05Vyloy $33.70Kimmtrak $29.20Xgeva $28.99Vectibix $28.99
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddie Thara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.